EzPAP Therapy Versus Non-invasive Ventilation Therapy

EzPAP Therapy Versus Non-invasive Ventilation for Hypercapnic Chronic Obstructive Pulmonary Disease Exacerbataion: a Randomized Clinical Trial

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06663462

Enrollment

Registered

2024-10-29

Start date

2022-12-15

Completion date

2024-06-30

Last updated

2024-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Invasive Ventilation

Keywords

Chronic Obstructive Pulmonary dissease, Non-invasive ventilation, EzPAP

Brief summary

This study compared EzPAP and noninvasive treatments of hypercapnic COPD attacks.

Detailed description

In this study, the effectiveness of NIV and EzPAP treatments was compared in patients admitted to the emergency department due to hypercapnic COPD exacerbation. Blood gas was taken at the 4th and 24th hours of treatment to evaluate the effectiveness.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Clinical diagnosis of Chronic obstructive pulmonary disease Dyspnea

Exclusion criteria

Cardiac failure Dead

Design outcomes

Primary

Measure	Time frame	Description
Blood gas	24 hours	Carbon dioxide height, low bicarbonate and presence acidosis measure in the blood gas

Countries

Turkey (Türkiye)

Outcome results